Optimas Capital’s Lam Research LRCX Stock Holding History

Optimas Capital’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,200	Closed	-$2.04M	–	22
2025 Q3	$2.04M	Buy	+15,200	New	+$1.61M	1.29%	23

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Optimas Capital's LRCX Position: Q4 2025 in Review

Optimas Capital sold out of Lam Research (LRCX) in Q4 2025, closing a stake of 15,200 shares — an estimated $2.04M sold.

Optimas Capital first reported a position in LRCX in Q3 2025 and held it in 1 quarter. The position peaked at $2.04M in Q3 2025. 2,386 funds tracked by Wall St. Rank hold LRCX as of Q4 2025.

Optimas Capital reported no remaining Lam Research position as of Q4 2025 after selling out during the quarter.
Optimas Capital sold 15,200 Lam Research shares in Q4 2025, an estimated $2.04M.
Optimas Capital first reported a position in Lam Research in Q3 2025 and held it in 1 quarter.
Optimas Capital's Lam Research position peaked at $2.04M in Q3 2025.
2,386 funds tracked by Wall St. Rank held Lam Research as of Q4 2025.

Based on Optimas Capital's 13F filing for Q4 2025, filed 11 Feb 2026.